Accuracy of MRI versus CT iMAGing to assess resectability following FOLFIRINOX for locally advancEd pancreatic cancer (IMAGE)
Completed
- Conditions
- pancreatic cancerpancreatic carcinoma10017991
- Registration Number
- NL-OMON43456
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Patients with locally advanced pancreatic cancer, without distant metastases, after 2 months of FOLFIRINOX chemotherapy undergoing explorative laparotomy
Exclusion Criteria
Contra-indications for MRI
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcome measure: correct assessment of tumor resectability according to<br /><br>DWI MRI, compared to standard CT. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Active tumor size on MRI and CT will be compared, and in patients receiving<br /><br>resection also compared to the active tumor size in the resected pathology<br /><br>specimen. </p><br>